Cargando…

Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo

BACKGROUND: Deleted in liver cancer 1 (DLC1) serves as an important RhoGTPase activating protein (RhoGAP) protein that terminates active RhoA signaling in human cancers. Increasing evidence has demonstrated that the tumor suppressive activity of DLC1 depends not only on RhoGAP activity, but also rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Lo-Kong, Ko, Frankie Chi Fat, Sze, Karen Man-Fong, Ng, Irene Oi-Lin, Yam, Judy Wai Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180446/ https://www.ncbi.nlm.nih.gov/pubmed/21966542 http://dx.doi.org/10.1371/journal.pone.0025547

Ejemplares similares

Deleted in Liver Cancer 1 (DLC1) Utilizes a Novel Binding Site for Tensin2 PTB Domain Interaction and Is Required for Tumor-Suppressive Function
por: Chan, Lo-Kong, et al.
Publicado: (2009)

Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma
por: Wong, Carmen Chak-Lui, et al.
Publicado: (2008)

Integrin-Linked Kinase Overexpression and Its Oncogenic Role in Promoting Tumorigenicity of Hepatocellular Carcinoma
por: Chan, Jenny, et al.
Publicado: (2011)

Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma
por: Yang, Xintao, et al.
Publicado: (2020)

Deleted in Liver Cancer 2 (DLC2) Was Dispensable for Development and Its Deficiency Did Not Aggravate Hepatocarcinogenesis
por: Yau, Tai On, et al.
Publicado: (2009)

Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
por: Leung, Zoe, et al.
Publicado: (2019)

Asymmetric localization of DLC1 defines avian trunk neural crest polarity for directional delamination and migration
por: Liu, Jessica Aijia, et al.
Publicado: (2017)

The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1
por: Liao, Yi-Chun, et al.
Publicado: (2007)

Endothelial DLC1 is dispensable for liver and kidney function in mice
por: Tan, Ying, et al.
Publicado: (2020)

DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
por: Wang, Dunrui, et al.
Publicado: (2016)

Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma
por: Wolosz, Dominika, et al.
Publicado: (2019)

The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity
por: Basak, Pratima, et al.
Publicado: (2015)

CDK5 opens the way for DLC1
por: Short, Ben
Publicado: (2014)

Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy
por: Ko, Frankie Chi Fat, et al.
Publicado: (2023)

Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma
por: Tian, Lu, et al.
Publicado: (2021)

Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma
por: Chan, Lo-Kong, et al.
Publicado: (2015)

Functional analysis of the Drosophila RhoGAP Cv-c protein and its equivalence to the human DLC3 and DLC1 proteins
por: Sotillos, Sol, et al.
Publicado: (2018)

Transcriptional Repressive H3K9 and H3K27 Methylations Contribute to DNMT1-Mediated DNA Methylation Recovery
por: Wong, Chun-Ming, et al.
Publicado: (2011)

Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma
por: XIE, CHENG-RONG, et al.
Publicado: (2015)

DLC1: a tumor suppressor that regulates Rho signaling
por: Tripathi, Brajendra K., et al.
Publicado: (2017)

Author Correction: Functional analysis of the Drosophila RhoGAP Cv-c protein and its equivalence to the human DLC3 and DLC1 proteins
por: Sotillos, Sol, et al.
Publicado: (2020)

The RhoGAP protein Deleted in Liver Cancer 3 (DLC3) is essential for adherens junctions integrity
por: Holeiter, G, et al.
Publicado: (2012)

Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas
por: Bujko, M., et al.
Publicado: (2016)

Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC
por: Chiu, Yung-Tuen, et al.
Publicado: (2023)

DLC-1:a Rho GTPase-activating protein and tumour suppressor
por: Durkin, Marian E, et al.
Publicado: (2007)

CDK5 is a major regulator of the tumor suppressor DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2014)

LD Motif Recognition by Talin: Structure of the Talin-DLC1 Complex
por: Zacharchenko, Thomas, et al.
Publicado: (2016)

Mechanotransduction in talin through the interaction of the R8 domain with DLC1
por: Haining, Alexander William M., et al.
Publicado: (2018)

Regulation of white and brown adipocyte differentiation by RhoGAP DLC1
por: Sim, Choon Kiat, et al.
Publicado: (2017)

DLC-1 facilitates germ granule assembly in Caenorhabditis elegans embryo
por: Day, Nicholas J., et al.
Publicado: (2022)

Functional antagonism between CagA and DLC1 in gastric cancer
por: Hinsenkamp, Isabel, et al.
Publicado: (2022)

DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
por: Song, L. J., et al.
Publicado: (2016)

Cooperation of DLC1 and CDK6 Affects Breast Cancer Clinical Outcome
por: Dai, Xiaofeng, et al.
Publicado: (2014)

DLC1 deficiency at diagnosis predicts poor prognosis in acute myeloid leukemia
por: Li, Xueqian, et al.
Publicado: (2022)

Underexpression of Deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma
por: Xiaorong, Li, et al.
Publicado: (2008)

Surface Reformation of Medical Devices with DLC Coating
por: Kaneko, Mao, et al.
Publicado: (2021)

Document Liveness Challenge Dataset (DLC-2021)
por: Polevoy, Dmitry V., et al.
Publicado: (2022)

EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
por: Au, Sandy Leung-Kuen, et al.
Publicado: (2013)

Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo
por: Lam, Sze-Kwan, et al.
Publicado: (2022)

Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma
por: Tsui, Yu-Man, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pqeftlhn167dd6lvgc737nerpp